VEMURAFENIB for Thyroid cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 119 adverse event reports in the FDA FAERS database where VEMURAFENIB was used for Thyroid cancer.
Most Reported Side Effects for VEMURAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Rash | 1,202 | 14.0% | 52 | 239 |
| Arthralgia | 783 | 9.2% | 27 | 79 |
| Off label use | 782 | 9.1% | 90 | 120 |
| Fatigue | 773 | 9.0% | 37 | 122 |
| Diarrhoea | 655 | 7.7% | 51 | 225 |
| Nausea | 601 | 7.0% | 46 | 137 |
| Pyrexia | 569 | 6.7% | 33 | 299 |
| Death | 505 | 5.9% | 504 | 37 |
| Alopecia | 445 | 5.2% | 8 | 32 |
| Decreased appetite | 383 | 4.5% | 22 | 79 |
| Vomiting | 342 | 4.0% | 36 | 141 |
| No adverse event | 341 | 4.0% | 3 | 2 |
| Photosensitivity reaction | 321 | 3.8% | 20 | 64 |
| Pruritus | 305 | 3.6% | 13 | 54 |
| Sunburn | 292 | 3.4% | 7 | 24 |
Other Indications for VEMURAFENIB
Malignant melanoma (2,548)
Product used for unknown indication (2,079)
Metastatic malignant melanoma (1,848)
Hairy cell leukaemia (236)
Neoplasm malignant (188)
Langerhans' cell histiocytosis (146)
Colon cancer (110)
Erdheim-chester disease (108)
Malignant melanoma stage iv (88)
Brain neoplasm malignant (68)
Other Drugs Used for Thyroid cancer
LENVATINIB (2,668)
CABOZANTINIB S-MALATE (1,615)
VANDETANIB (591)
DABRAFENIB (583)
TRAMETINIB DIMETHYL SULFOXIDE (482)
SORAFENIB (399)
LEVOTHYROXINE (299)
PAZOPANIB (264)
PRALSETINIB (199)
CABOZANTINIB (125)